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Background: ATF2 mediated cytochrome c release is the formation of a channel with some unknown factors larger
than that of the individual proteins. BHS-only proteins (BH3s), such as Bim, could induce BAX and VDAC, forming a
new channel. According to this facts, we can speculated that there is possible signal relationship with BH3s and
ATF2, which is associated with mitochondrial-based death programs.
Methods: The growth inhibitory effects of mitochondrial ATF2 were tested in cancer cell lines B16F10, A549, EG7,
and LL2. Apoptosis was measured by flow cytometry. The effects of ATF2 and levels of apoptosis regulatory
proteins were measured by Western blotting. The interaction of proteins were evaluated by immunoprecipitation
analysis. The in vivo antitumor activity of mitochondrial ATF2 were tested in xenograft B16F10 models.
Results: Genotoxic stress enabled mitochondrial ATF2 accumulation, perturbing the HK1-VDAC1 complex, increasing
mitochondrial permeability, and promoting apoptosis. ATF2 inhibition strongly reduced the conformational activation
of Bim, suggesting that Bim acts downstream of ATF2. Although Bim downregulation had no effect on ATF2 activation,
Bim knockdown abolished VDAC1 activation; the failure of VDAC1 activation in Bim-depleted cells could be
reversed by the BH3-only protein mimic ABT-737. We also demonstrate that silencing of ATF2 in B16F10 cells
increases both the incidence and prevalence of tumor xenografts in vivo, whereas stably mitochondrial ATF2
transfection inhibited B16F10 tumor xenografts growth.
Conclusions: Altogether, these results show that ATF2 is a component of the apoptosis machinery that involves
a hierarchical contribution of ATF2, Bim, and VDAC1. Our data offer new insight into the mechanism of
mitochondrial ATF2 in mitochondrial apoptosis.
Keywords: Mitochondria, ATF2, Bim, VDAC1, ApoptosisIntroduction
As one member of activator protein-1 (AP-1) transcrip-
tion factor, a growing number of transcription dependent
and independent functions have been described, while
attesting to its capacity to regulate diverse and often op-
posing functions, which implicated some of the most
challenging therapeutic targets [1,2]. Growing evidence
indicates that a cytoplasmic localization of activating
transcription factor 2 (ATF2) is associated with cell death
in disease or cellular stress states [3]. Following ionizing
irradiation with prostate cancer cells, ATF2 had been* Correspondence: guochunbao@foxmail.com
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unless otherwise stated.observed to accumulate in the cytoplasm [4]. Further-
more, the forced expression of cytoplasmic ATF2 peptides
induces melanoma cell death and thereby reduces the
transcriptional activity of endogenous ATF2 [5]. Fur-
ther studies have shown that genotoxic stress induces
translocation of nuclear ATF2 to the cytoplasm, which
coincides with the reduced transcriptional activity of
ATF2 [6,7].
Because ATF2 localizes at the mitochondrial outer
membrane result in reduced mitochondrial membrane po-
tential, with concomitant leakage from the mitochondria,
hallmarks of mitochondrial-dependent cell death. Hence,
ATF2 recruitment to the mitochondria is associated with
its tumor suppressor activities. Despite the fact that func-
tional studies of ATF2 provide no compelling reason for
decreasing HK1 bind to VDAC1 [8,9], possible mechanisms is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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known factors larger than that of the individual proteins
to mediate cytochrome c release. ATF2 also reported
play an important role in the conformation and thus
activation of Bax [1]. Conformational changes and
homo-oligomerization are two critical events associated
with the activation of BAX/BAK by BH3s and VDAC1.
However, the underlying mechanisms remain unsettled.
It is especially complex for BAX due to its change in the
subcellular localization during apoptosis. An under-
standing of the precise mechanisms underlying its
function at the mitochondria, could provide a platform
for identifying small molecues that affect the involved
signaling. Similarly, it will be important to determine its
mitochondrial function and their possible relationship
to the Bcl-2 family protein signaling that is associated
with mitochondrial-based death programs [10,11]. Indeed,
evidence involved in activator BHS-only proteins (BH3s),
such as Bim, has been presented, which could induce
BAX and VDAC reconstituted into liposomes, forming a
new channel at the MOM [12-14]. According to this facts,
we can speculated that there is possible signal relationship
with BH3s and ATF2, which is related to mitochondrial
involved apoptosis.
Here, we investigate the role of ATF2 in mitochondrial
apoptosis and the mechanisms underlying the interaction
of ATF2 with other proapoptosis proteins. Our work re-
vealed that, at the membrane of mitochondrial, the hier-
archical involvement of Bim, VDAC1, and ATF2 break the
hexokinase-1 (HK1) and voltage-dependent anion channel-
1 (VDAC1) complexes, thereby enhancing mitochondrial
permeability and releasing cytochrome c. The exploration
of the mechanisms for ATF2 mitochondrial localization
offers a theoretical basis to guide cancer cells to apoptosis.
Methods
Cell culture, antibodies, regents, and drugs
The tumor cell lines B16F10, A549, EG7, and LL2 were
selected for this research. These cells were gifts of Prof.
Hongbo Luo, Harvard University, and were maintained
in RPMI 1640 (Gibco, Gaithersburg, USA) or DMEM
(Life Technologies, CA, USA), each supplemented with
10% fetal bovine serum and penicillin G sodium and
streptomycin sulfate (100 units/ml) in a humidified atmos-
phere of 5% CO2 and 95% air. ABT-737 (Selleckchem,
Souffelweyersheim, France) used at 1 μM final concentra-
tion. MitoTracker Red CMXRos (M7512) and leptomycin
B (LMB) (sc-358688) were purchased from Invitrogen
(Eugene, OR, USA) and Santa Cruz Biotechnology (Santa
Cruz, CA, USA), respectively. All antibodies including
ATF2(C-19, sc-187), p-ATF2(F-1, sc-8398), COX4 (D-20,
sc-69359), Bim (N-20, sc-8265), PUMAα (N-19, sc-19187),
Bax (P-19, sc-526), cytochrome c (C-20, sc-8385), VDAC1
(B-6, sc-390996), Mcl-1 (S-19, sc-819), β-Actin (C4, sc-47778)were purchased from Santa Cruz Biotechnology. The
monoclonal anti-HK1(C35C4, 2024) antibody was ob-
tained from Cell Signaling Technologies (MA, USA).
Paclitaxel ((PTX, 33069-62-4) was obtained from Beijing
Zhongshuo Pharmaceutical T & D Co., Ltd (Beijing,
China). Staurosporine (STS), cisplatin, 4,4′-diisothiocya-
nostilbene-2,2′-disulfonic acid (DIDS), carbonyl cyanide
m-chlorophenylhydrazone (CCCP), and propidium iodide
were purchased from Sigma (St. Louis, MO, USA). The
annexin V-FITC kit (K201-100) was purchased from
Biovision. PTX was purchased from Calbiochem (La
Jolla, CA) and dissolved in 100% dimethyl sulfoxide to
produce a stock solution of 1.0 mM.
RNA interference
Cells were transfected at ~70-90% confluence (approxi-
mately 1 × 105 cells/ml density). ATF2-specific shRNA
clones (ID: TRCN0000013713, Sigma, USA) were ob-
tained from Open Biosystems (catalog no. RHS4533).
Lentiviral particles packaged with ATF2 shRNA or scram-
bled shRNA (control) were generated and spin infected
into the target cells in the presence of 10 mg/ml polybrene
(Sigma, USA) [15]. The transfection of a synthetic siRNA
(25 nM) for VDAC1 was performed with Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. The sense sequence of the
double-stranded siVDAC1 siRNA was 5′ AGUGACGGG
CAGUCUGGAATT 3′. A scrambled siRNA, which served
as a negative control, was purchased from GenePharma
(Shanghai, China). HK1 siRNAs (ID: 1599) were obtained
from Ambion (USA). The same siRNA reagents were
added to the medium at 24 hours post-transfection for
24 hours. The western blot analysis was used to evaluate
gene silencing effects. The appropriate controls were
included during the entire siRNA knockdown process,
confirming the specificity of the siRNA. For the construc-
tion of tetracycline-regulated gene expression vectors ex-
pressing ATF2T52A mutants (mitochondria localization),
DNA was amplified by PCR using pEF-HA-ATF2 (WT,
T52A mutants), a gift of Ze’ev A. Ronai (Sanford-
Burnham Medical Research Institute, La Jolla, CA 92037,
USA), and subcloned into pTHE, resulting in pTHE-WT,
ATF2T52A, which were transfected into B16F10 and screened
with tetracycline.
Cell viability determination (MTT Assay)
Subconfluent monolayers of the B16 cell line were estab-
lished in 96-well plates. After overnight incubation, the cells
were exposed to different treatments in a medium contain-
ing 0.5% fetal bovine serum for 72 hours; 10-μl aliquots of
3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyl-tetrazolium brom-
ide (MTT) solution (10 mg/mL in PBS) were added,
followed by 100 μL of 10% sodium dodecylsulfate (SDS)
to dissolve the formazan crystals formed. The absorption
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(Anthos Mikrosysteme GmBH, Germany) at a wavelength
of 570 nm. A standard optical density of the untreated
control cells was considered at 100% viability. Survival
was evaluated by the absorbance of the treated cells nor-
malized to the controls.
Confocal immunofluorescence assays
Cells from different treatment groups were incubated
with MitoTracker Red (25 nM) for 15 minutes, fixed,
permeabilized, and stained with antibodies for the detec-
tion of ATF2 (20 F1). The primary antibodies were re-
vealed using either goat anti-rabbit or anti-mouse IgG
conjugated to Alexa 488 (green) (1:500, diluted in blocking
solution) from Molecular Probes-Invitrogen. After 1 hours
of incubation, the slides were mounted, and the stained
cells were analyzed using a confocal microscope (Leica
Microsystems Heidelberg GmbH, Heidelberg, Germany).
Apoptosis assay by annexin V/propidium iodide staining
At various time points, control and treated cells were
collected following treatment and subjected to apoptosis
measurement using the annexin V/propidium iodide (PI)
detection kit (R&D Systems) according to the manufac-
turer’s instructions. A total of 10,000 cells (within whole-
cell gates) per replica (3 independent experiments) were
subjected to a flow cytometric analysis to evaluate the
green fluorescence of annexin V and the red fluorescence
of DNA-bound PI. All the data were analyzed with FlowJo
software (TreeStar, OR).
Cytochrome c release assay
Isolated tumor cells (5 × 107) were collected and assayed
with the Cytochrome c Apoptosis Assay Kit (Cat. #K257-
100, Biovision, CA, USA). Briefly, the cells were homoge-
nized with the cytosol extraction buffer provided in the kit
and then centrifuged at 700 × g for 10 minutes at 4°C to
remove the debris. The supernatant was then centrifuged
at 10,000 × g for 30 minutes at 4°C; the pellet contained
the mitochondrial fraction, and the supernatant was col-
lected as the cytosolic fraction. These fractions were ana-
lyzed for cytochrome c by western blotting using the
cytochrome c antibody provided in the kit.
Immunoprecipitation and analysis of protein expression
Cells, transfected as indicated, were lysed in the buffer
for 45 min. Lysate aliquots of equal concentration were
then incubated overnight with 2 μg of anti-ATF2, −VDC1,
−Bim, and -Puma antibodies in an overhead rotator,
followed by 20 μl protein G-Sepharose beads (Amersham
Pharmacia Biotech, Uppsala, Sweden) for 2 h. The immu-
noprecipitated proteins were incubated at 70°C for 15 min
and analyzed by immunoblotting with conformation-
specific primary antibodies against ATF2, VDC1, Bim,Puma, HK1, and VDAC1 (Cell Signaling Technology).
β-actin (Chemicon International, Temecula, CA, USA)
was performed as loading control.
Cell fractionation
Fractions of cytoplasm nuclear, and mitochondria were
separated using a commercial Qproteome mitochondria
extraction kit and a Qproteome nucleus extraction kit
(Qiagen, Toronto, ON, Canada). Briefly, cells were firstly
lysed and centrifuged for 5 min at 1000 × g to remove
unbroken cells and nuclei. The supernatant was sepa-
rated from the pellet and centrifuged at 2,200 × g for
20 min at 4°C to pellet the mitochondria-enriched heavy
membrane fraction. The resulting supernatants were com-
bined and further centrifuged at 4°C at 12,000 × g for
30 min at 4°C to obtain the cytoplasmic fraction. An
immunoblot analysis was performed as described below.
Western blot analysis
Cells from different treatment groups were lysed using a
protein extraction buffer. Total proteins (10 μg) were sepa-
rated by SDS-PAGE and transferred to nylon membranes
(Shanghai Sangon Biotech, Shanghai, China). The blots
were hybridized with antibodies indicated above. The sec-
ondary antibody, horseradish peroxidase-coupled immuno-
globulin (Jingmei Biotech Co., Ltd. Shenzhen, China), was
then inculated for 1 h. β-actin (Sigma) was used as loading
control. All critical blots and immunoprecipitation experi-
ments were repeated at least three times.
Mitochondrial membrane potential detection
Cells were treated and resuspended in serum-free medium
at a concentration of 1 million cells/ml. Each sample was
added 5 μl of JC-1 dye (200 μM) for incubation at 37°C,
30 min. The samples were measured by flow cytometry,
with 10,000 events collecting. Results were also observed
under fluorescence microscopy.
Tumor implantation procedure
C57BL/6 female (8–10 weeks old) mice were purchased
from Chongqing Medical University Animal Center
(Chongqing, China). All animal experiments were per-
formed with the approval of the Animal Institute
Committee. B16F10 cells stably transfected with ATF2
shRNA, ATF2T52A or with empty vector (1.0 × 106/0.1 ml)
were injected subcutaneously. The tumor sizes were
evaluated using calipers every 2 to 3 days, and the tumor
volumes were calculated using the formula: volume =
(a2 × b)/2 (a, the short tumor length; b,the long tumor
length). In one arm of the experiment, nonnecrotic,
single-cell suspensions from tumor tissue were prepared
for FACS staining of annexin V/propidium iodide. A por-
tion of the freshly isolated tumor tissue was subjected to a
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described in the results section.
Statistical analysis
Data are expressed as means ± standard errors of the mean
(SEM). Unless indicated otherwise, comparisons were de-
termined using the Student’s t test and one-way ANOVA.
P < 0.05 were considered as significance difference.
Results
ATF2 mitochondrial localization is critical for
genotoxic-induced apoptosis
To test the contribution of mitochondrial ATF2 to
apoptosis, we measured the cytotoxic effect of genotoxic
insults on several cancer cell lines by a cell viability
analysis while measuring the ATF2 mitochondria accu-
mulation within these cells. As shown in Figure 1A,
mitochondrial accumulation was induced in the mouse
tumor cell line B16F10 as early as 4 hours after pacli-
taxel (PTX) treatment, whereas leptomycin B (LMB),
the nuclear export inhibitor, prevented the ATF2 mito-
chondrial localization. PTX also resulted in 20% growth
inhibition. Similar effects were observed in other cell
types, including A549, EG7, and LL2 (Figure 1B). This
reduced viability was due to the activation of an apop-
totic program, as revealed by a flow cytometric analysis
The induction of apoptosis can also be prevented by
pretreatment with LMB (Figure 1C).
We next compared the contribution of ATF2 to apop-
tosis in cells using ATF2 shRNA transfection. The B16F10-
shATF2 cells exhibited more resistance to PTX-induced
apoptosis than the control phenotype (P <0.01) (Figure 1D).
To assess the effect of elevated mitochondrial ATF2 ex-
pression in B16F10 cells, cells were transfected with the
ATF2T52A expression vector, which preferentially localizes
to the mitochondria [3]. The exposure of cells expressing
mitochondrial ATF2 to PTX exhibit significantly higher
Annexin-V uptake (i.e., cell death) compared to the cells
expressing the control vector (Figure 1D). We also
found that genotoxic stimuli could also induce a high
level phosphorylated (p-ATF2, at Thr69/71), the active
form of mitochondrial ATF2 (Figure 1E), consistent
with the cell viability performance after challenge with
genotoxic stimuli.
Bim and VDAC1 are required for ATF2-mediated cell
apoptosis
As Bim and VDAC1 are reported to induce mitochon-
drial apoptosis, we explored the roles of these proteins
in ATF2-related cell death. As with the cells possessing a
specific level of ATF2, all the cell types were sensitive to
apoptosis induction by apoptosis-inducing agents, such
as PTX, staurosporine (STS), and cisplatin, which act
through the activation of ATF2 (Figure 2A).Approximately 80% of the ATF2T52A-expressing cells
underwent apoptosis upon exposure to PTX, which
was significant increased compared with WT control
(Figure 2B). the efficience of ATF2T52A transduction
was proved in Figure 2B. We next inhibited VDAC1
function in ATF2T52A-expressing cells using a chemical
inhibitor of VDAC1, 4,4′-diisothiocyanostilbene-2,2′-
disulfonic acid (DIDS). As expected, apoptosis induc-
tion by ATF2 was significantly prevented upon VDAC1
depletion (Figure 2C).
In contrast to ATF2T52A-expressing cells, the ATF2-
depleted cell exhibited resistance to apoptosis induction
by PTX (Figure 2D). We also investigated the possibility
of restoring the sensitivity of ATF2-depleted cells to
PTX with ABT-737, the pharmacological mimetic of
Bcl-2 homology domain 3 (BH3), which is thought to
act by displacing Bim from Bcl-2. We firstly separately
confirmed the efficiencies of the knockdowns (ATF2
and Bim) by Western blot analysis (Figure 2B). PTX
treatment alone resulted in lower levels of annexin-V in
the ATF2-depleted cells. Conversely, ABT-737 sensi-
tized the ATF2-depleted cells to PTX induced apoptosis
as efficiently as the control cells (Figure 2D). Notably,
the siBim conferred resistance to treatment, which com-
pletely abrogated the effects of ABT-737 (Figure 2E).
ATF2 competes with HK1 to bind VDAC1
As VDAC1 played an critical role in mitochondrial perme-
abilizing pores, we next addressed whether the mitochon-
drial translocation of ATF2 perturbs VDAC1 in these
pores in B16F10 cells. PTX was predictably observed to
significantly increase the protein level of ATF2, bur no
influence the HK1 and VDAC1 level in the mitochon-
dria of B16F10 cells after 4 h of treatment (Figure 3A).
To identify the interactions of ATF2 with VDAC1 or
HK1, endogenous VDAC1 were immunoprecipitated
and bloted with ATF2 in B16F10 cell lysates prior to
and after PTX stress. ATF2 and VDAC1 interaction
wwere clearly observed after PTX treatment (Figure 3B),
whereas the interaction between HK1 and VDAC1 was
disturbed by endogenous ATF2 accumulation (Figure 3B)
and ATF2 depletion promoted the association of HK1
and VDAC1.
Because we observed that the level of VDAC1 was ele-
vated in the ATF2-overexpressing B16F10 cells, we next
assessed whether VDAC1 depletion would affect the
mitochondrial accumulation of ATF2. As expected, we
observed that the protein levels of ATF2 were signifi-
cant altered after VDAC1 knockdown (Figure 3C). At
the same time VDAC1 depletion seems promoted HK1
association with ATF2 under basal conditions and fol-
lowing PTX treatment (Figure 3C). We then observed
that more mitochondrial ATF2 accumulation in the HK1
depletion cells even exposure with PTX (Figure 3C),
Figure 1 (See legend on next page.)
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Figure 1 Role of ATF2 in PTX-induced apoptosis in various tumor cell lines. (A) Control, 100 nM PTX-treated (12 hours treatment), and
ionizing radiation-treated (IR, 5 Gy) cells were permeabilized and stained for ATF2. The nuclear localization of ATF2 is indicated by costaining
with DAPI (Vector Laboratories, UK). Scale bar: 20 μm. (B) The inhibition of cell viability with PTX or leptomycin B (LMB) and PTX cotreatment was
assessed by the (4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide assay. Data are means ± s.e.m and represent the means from three
different experiments. (C) Diagrams of flow cytometry showing the results from the detection of apoptosis with the cells treated as indicated above.
(D) Shown is a diagram of three similar FACS apoptosis assay using Annexin V/PI staining for B16F10 cells stably transfected with scrambled or ATF2
shRNA incubation in the absence or presence of PTX for 12 hours. Statistical analysis of apoptosis in the different treatments was performed
by ANOVA and t-tests; *P < 0.01. Data are means ± s.e.m (n = 4). (E) Different fractionations purified from the indicated cells were subjected to
western blotting with COXIV and β-Actin as the loading control. Representative figures of multiple experiments are shown. The morphometry
of p-ATF2 and ATF2 are indicated at right. The columns provide average values of at least 3 independent experiments performed in triplicate;
the bars, SE. *P < 0.01 compared with the corresponding control.
Liu et al. Cancer Cell International  (2015) 15:34 Page 6 of 14suggesting that ATF2 accumulation was affected by
HK1 reduction, and the VDAC1 protein level immuno-
precipitated from ATF2 was significant improved, suggesting
HK1 depletion facilitated the association of mitochondrial
ATF2 with VDAC1 (Figure 3C). These results suggest that
HK1 and ATF2 most likely compete for binding to VDAC1
on the outer mitochondrial membrane.
We further demonstrated the VDAC1 and ATF2 inter-
action by cellular distribution using confocal fluorescence
microscopy. Under basal conditions, ATF2 is located in the
nucleus and cytoplasm. In the PTX-treated cells, ATF2
fluorescence was attenuated with the nuclear localization
of ATF2 and promoted with mitochondrial localization,
as punctuate, MitoTracker-labeled mitochondrial struc-
tures, suggesting that PTX treatment enabled ATF2 nu-
clear export and mitochondrial localization (Figure 3D).
MitoTracker Red is highly sensitive to mitochondrial mem-
brane potential (mmp) and thus decreased labeling exhib-
ited decreased mmp in PTX treated cells. Consistently, the
cell expressing the VDCA1 siRNAi showed decreased
mitochondrial ATF2 localization, even in the presence of
PTX, as detected by mitochondrial fractionation and
diffuse staining throughout the cytosol (Figure 3D) in
comparison with the the empty vector expressing cells,
suggesting that the ATF2 mitochondrial binding re-
quired VDAC1. Additionally, HK1 depletion enhanced
the ATF2 translocation in mitochondrial following PTX
stress (Figure 3D).
Hierarchical relationship between ATF2, Bim, and VDAC1
Previous studies have shown that VDAC1 promotes the
mitochondrial accumulation of BAX to trigger the subse-
quent cytochrome c release, however, Bim, a mitochon-
drial membrane protein, is also essential for the activation
of BAX and release of cytochrome c (14). Accordingly, we
examined whether ATF2 would affect the activation status
of Bim, thereby promoting the interaction between BAX
and VDAC1.
Consistently, we found that PTX treatment resulted in
Bim and Puma mitochondrial expression, as revealed by
a fractionation analysis of immunoblotting (Figure 4A).
A 62% induction in ATF2 levels caused the efficientactivation of Bim, whereas ATF2 depletion reduced the
activation of Bim and Puma to minimal levels (Figure 4A).
Next, we performed immunoprecipitation assays to
directly measure the interaction between Bim and ATF2
or VDAC1 in B16F10 cell lysates prior to and after PTX
treatment. We did not find a direct binding between Bim
and ATF2 or Bim and VDAC1; however, when Bim was
silenced with siRNA, we observed a significant inhibition
of Bim but no altered ATF2 activation (Figure 4B). These
results suggest that ATF2 interrupts PTX involved signal-
ing at the upstream of Bim level. Furthermore, Bim deple-
tion strongly inhibited the PTX-induced VDAC activation,
whereas VDAC1 depletion had no effect on Bim induction
(Figure 4C). Taken together, we postulate that Bim might
take effect at the upstream of VDAC1 and downstream
of ATF2.
We next explored the possibility of restoring the
ATF2-VDAC pathway by ABT-737. We found that PTX
alone failed to activate BAX in ATF2-depleted cells,
whereas ABT-737 could rescue the inhibition of BAX
translocation to mitochondria by an ATF2-targeting
shRNA (Figure 4D). A fractionation analysis revealed
that the PTX and ABT-737 combination efficiently elicit
BAX activation in ATF2-targeting shRNA cells (Figure 4D),
but ABT-737 could not rescue the inhibition of BAX
translocation by VDAC inhibition (DIDS) (Figure 4E),
which were further verified in cellular distribution using
confocal fluorescence staining (Figure 4G). We also found
that VDAC1 was activated by ABT-737 in cells that were
apt to apoptosis, whereas VDAC1 inhibition by DIDS
induced a large extent or complete resistance to PTX treat-
ment even in the presence of ABT737, which was consist
with the finding that VDAC1 was activated by ABT-737 in
cells that were also sensitive to PTX (Figure 4F).
Notably, Bim depeltion completely abrogated the effects
of ABT-737, preventing it from regaining the sensitive of
ATF2-depleted cells to PTX (Figure 2D). Altogether, these
results indicate that ATF2 sensitizes cells to apoptosis by
promoting Bim and hence to directly facilitate VDAC1
activation. Overall, our study reveals an essential axis of
activator ATF2 and Bim and Puma in activating the
mitochondrial death program.
Figure 2 (See legend on next page.)
Liu et al. Cancer Cell International  (2015) 15:34 Page 7 of 14
(See figure on previous page.)
Figure 2 Bim and VDAC1 are involved in ATF2-associated apoptotic induction. (A) Different cancer cell lines were subjected to
mitochondria-mediated apoptosis with PTX, STS (1.25 μM, 5 hours), and cisplatin (50 μM, 30 hours) and apoptosis analysis by Annexin V/PI
staining. Data are means ± s.e.m and represent three different experiments. *P < 0.01, ANOVA, versus Control. (B) The B16F10 cells were
transfected with siBim (low panel), shATF2 (middle panel) and ATF2T52A (up panel), and whole-cell lysate for siBim and shATF2 or fractionated to
Nuclear and mitochondrial fractions for ATF2T52A were subject to immunoblot analysis with indicated antibodies. β-actin loaded as control. The
morphometry of ATF2 are indicated at right. The columns provide average values of at least 3 independent experiments performed in triplicate;
the bars, SE. *P < 0.01 compared with the corresponding control. (C) B16F10 cells, transfected with ATF2T52A or not were treated with PTX
(100 nM, 12 hours), pretreatnent with or without DIDS (100 μM, 1 h). Cells were then subjected to measurement of apoptosis by Annexin V/PI
staining. Columns, mean of three individual experiments; bars, s.e.m. *P < 0.01, ANOVA. (D) Cells expressing shATF2 were exposed in the absence
or presence of ABT-737 (1μM, 24 h) and subjected to mitochondria-mediated apoptosis induction by PTX. Cells were then subjected to measurement
of apoptosis by Annexin V/PI staining. Columns, mean of three individual experiments; bars, s.e.m. *P < 0.01, ANOVA. (E) Cells expressing siBim
were exposed in the absence or presence of ABT-737 and then subjected to mitochondria-mediated apoptosis induction by PTX. FACS analyses
of apoptotic cell death were performed using Annexin V/PI staining. Columns, average values of three independent experiments; bars, s.e.m.
*P < 0.01, ANOVA.
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promoting cytochrome c release
We next verify whether the caspase-dependent cell death
can be extrapolated to canonical ATF2 mitochondrial
localization. As indicated, cells expressing ATF2 shRNAi
were exposed to PTX, and the mitochondrial membrane
potential was analyzed to quantify JC-1 release. Consistent
with previous reports, PTX caused a large, rapid decrease
in the average red fluorescence signals compared to the
controls, whereas the green fluorescence signals increased
(Figure 5A). The ATF2 shRNAi-transfected B16F10 cells
also did not exhibit alterations in either of the fluores-
cence signals in comparison with the cells transfected with
the empty vector. In this setting, the fluorescence signals
did not exhibit alterations following genotoxic stress com-
pared to the control cells, when VDAC1 function was
inhibited using DIDS, whereas the combination of PTX
and ABT-737 caused increased green fluorescence sig-
nals in ATF2 depletion cells as efficiently as in control
cells (Figure 5B). Thus, ABT-737 can restore the mito-
chondrial membrane potential alteration resulting from
the loss of ATF2.
This observation was further corroborated by cyto-
chrome c cytofluorometry and immunoblotting. The punc-
tuate mitochondrial localization of cytochrome c was
altered upon PTX to a diffuse cytoplasmic localization in
the cells expressing native ATF2 (Figure 5C), which indi-
cated that mitochondria cytochrome c had translocated to
the cytosol. In contrast, the ATF2 depletion cells exibited a
decreased intensity with diffuse staining (Figure 5C), which
could be rescued by ABT-737, as evidenced by the release
of cytochrome c into the cytoplasm. These results suggests
that the apoptotic resistance of the ATF2 depletion cells is
owing to the inability of cytochrome c release, further
verified by western blotting to confirm the presence of
cytoplasmic cytochrome c (Figure 5D). These findings
clearly show that ATF2 is critical for cytochrome crelease and suggest a link between mitochondrial ATF2
and cytochrome c release. Thus, ABT-737 can rescue
the mitochondrial apoptotic response to PTX in B16F10
cells, indicating that ATF2 localization is able to activate
the mitochondrial death pathway and trigger cell death
in B16F10 cells through the cytochrome c release pathway.A decrease in ATF2 correlates with in vivo tumorigenicity
We next examined the tumorigenic effect of ATF2 in the
B16F10 cell line using RNA interference or mitochondrial
ATF2 upregulation using ATF2T52A transduction. ATF2
mRNA levels were significantly reduced in the ATF2-
depleted xenograft tumors, slightly increased in the
ATF2T52A transduction xenograft tumors compare to the
parental B16F10 empty vector control groups (Figure 6A).
Tumor xenografts of B16F10 cells stably transfected
with ATF2 shRNA exhibited a higher tumorigenic com-
pared to the empty vector control (Figure 6B). As indi-
cated in Figure 6B, the mean tumor volume of the
B16F10-shATF2 group was significantly larger than the
corresponding B16F10 groups (P < 0.05, One way
ANOVA), whereas increased mitochondrial ATF2 is ob-
served to block melanoma progression (Figure 6C, D).
Similarly, the life span of the xenograft mice were also ob-
served decrease in the B16F10-shATF2 cells and increase
in the ATF2T52A transduction B16F10 cells. Fractionation
western blotting analysis using mitochondrial and nuclear
fractions from mammary tumors indicated that the ATF2
protein was enhanced in the tumors from ATF2T52A
transduction cells and almost undetectable in the tumors
derived from the ATF2-depleted cells (Figure 6E). Flow
cytometry FACS analysis with annexin V and PI staining
was used to determine cell apoptosis, with the early
apoptotic cells in ATF2-depleted B16F10 melanoma
cells being significantly lower compared to the empty
vector-transfected B16F10 cells (Figure 6F), suggesting
Figure 3 The interaction of VDAC1 and HK1 with ATF2 in response to apoptosis induction. (A) B16F10 cells stably transfected with
scrambled or ATF2 shRNA were treated with PTX or PBS. Mitochondrial and Cytoplasmic extracts were subjected to an immunoblot analysis
with the indicated antibodies. The positions of the molecular weight markers (in kDa) are noted on the right. (B) B16F10 cells stably transfected
with ATF2 shRNA or ATF2T52A were crosslinked and lysed. VDAC1 was immunoprecipitated and subjected to an immunoblot analysis with the
indicated antibodies. (C) B16F10 cells stably transfected with HK1 shRNA or VDAC1 shRNA were subjected to immunoprecipitated for ATF2 and
then measured with immunoblot analysis using the indicated antibodies. (D) Cells stably transfected with HK1 shRNA, ATF2 shRNA, and VDAC1
shRNA were immunofluorescently stained with MitoTracker and anti-ATF2 antibodies after exposure with or without PTX and visualized using
confocal microscopy (Olympus 1X81) (Scale bar: 20 μm).
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B16F10-induced tumor cells.
Discussion
The cytosolic localization of ATF2 has been associated
with tumor suppressor activity in some solid tumors
[7,16-20]. However, targeting this pro-apoptotic protein
for tumor treatment requires knowledge and understand-
ing of their modes of action. Several possible mechanisms
of action have been proposed in the previous reports. Thepresent work offer insight into the mechanism by which
mitochondrial ATF2 might help to cytotoxic stress in-
duced mitochondrial membrane permeabilization (MMP).
While the ATF2 still localizes to mitochondria and func-
tions normally, releases of cytochrome c and apoptotic cell
death were induced. Mitochondrial ATF2 impairs HK1/
VDAC1 complexes and mitochondrial membrane integ-
rity, sensitizing cells to apoptosis. Moreover, we demon-
strated that apoptosis induction hierarchically involves Bim
and VDAC1. The proapoptotic protein Bim was shown to
Figure 4 (See legend on next page.)
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Figure 4 ATF2 affects the PTX-elicited activation of Bim and Puma. (A) B16F10 cells treated with PTX were examined for the subcellular
localization of proteins by western blotting, with the protein weights indicated (in kDa). COXIV was shown as a loading control of mitochondrial
sample; β-Actin was shown as an loading control of cytosolic fraction. B16F10 cells stably transfected with scrambled or Bim SiRNA (B), VDAC1
SiRNA (C) and ATF2 shRNA (D) were subjected PTX treatment and then subject to immunoblot analysis with the indicated antibodies. B16F10
cells were preincubated with or without DIDS (100 μM, for 1.5 h), followed by ABT737 (1μM, 24 h) and PTX treatment (100 nM, 12 h). Cells were
subjected to immunoblot analysis with the indicated antibodies (E) and FACS apoptosis analyses Annexin V/PI staining (F), *P < 0.01, ANOVA.
Data are means ± s.e.m. (n = 5). (G) B16F10 cells stably transfected with scrambled or ATF2 shRNA were incubated with ABT-737 alone or in
conjunction with PTX. The cells were immunofluorescently stained with the indicated antibodies and visualized using confocal microscopy
(Olympus 1X81) (Scale bar: 20 μm).
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ATF2. Finally, a decrease in ATF2 mitochondrial expres-
sion led to enhanced tumorigenesis ability in vivo.
ATF2 appears to be a convergence point for a variety
of cellular survival and death signals. Considering that
the major cellular site targeted by mitochondrial ATF2 is
the mitochondrion, several mechanisms were proposed
to explain the action of such proteins at the mitochondria
[1]. In accordance with previous results [3], genotoxic
stress in melanoma cells was found to induce the predom-
inant mitochondrial localization of ATF2 and promote cell
death. The overexpression of mitochondrial ATF2 induced
mitochondrial depolarization, a phenomenon associated
with apoptosis, regardless of the cellular host. We also in-
dicated that ATF2 depletion cells have a lower capacity to
induce apoptosis in response to genotoxic stress, suggest-
ing that lying in the mitochondrial outer membrane
(MOM), ATF2 is a conserved mitochondrial element of
the death machinery. These findings are consistent with
previous results that the cytosolic ATF2 is necessary for
mitochondria-mediated apoptosis (29). ATF2 is required
for cytochrome c release when induced by various stimuli.
Previous results indicated that the cytosolic ATF2 is ne-
cessary for mitochondria-mediated apoptosis [15], con-
sistent with current findings. Cytochrome c release also
found to ATF2 requirement with various stimuli expos-
ure. Indeed, apoptosis induced of by PTX, cisplatin, and
STS, acting on multiple pathways, all ultimately led to
cytochrome c release in cells expressing native ATF2.
It has been shown that ATF2 might regulate and con-
trol the availability of VDAC1 to HK1, Bcl-2, and Bcl-xL
[3]. Herein, we clearly show that ATF2 can interact with
VDAC1 to disrupt the HK1/VDAC complex in various
cancer cells, suggesting that ATF2 might bind to
VDAC1 in competing with HK1 and thus promote cyto-
chrome c release.
It has also been suggested that the proapoptotic Bim
protein induces conformational changes in BAX to pro-
mote the targeting and homo-oligomerization of BAX at
the MOM [21]. The proapoptotic proteins BAX and
BAK were proposed to form heterodimeric complexes,
with physical associations between VDAC1 and BAXbeing reported in various experimental models [22].
Here, we not only demonstrated a direct interaction of
Bim with VDAC1 but also showed the function of this
interaction in mediating the proapoptotic activity of
ATF2 to modulate the interaction of VDAC1 and BAX.
Our results point to a role for ATF2 as an activator of
Bim. Serial siRNA experiments and epistatic analyses
suggest that ATF2triggers the conformational activation
of Bim, whereas, VDAC1 activation (downstream of ATF2
signal) need the Bim expression. Accordingly, VDAC1 does
not adopt its active conformation when Bim is absent,
whereas ATF2 remains inactive. Furthermore, pharmaco-
logical inhibition of Bcl-2/Bcl-XL with the BH3 mimetic
ABT-737, was able to rescue the defect of VDAC1 inactiva-
tion triggered by ATF2 deficient. It is worth noting that in
the conditions used here, ABT-737 was not able to induce
VDAC1 activation per se.
Therefore, our results define the pathway by which
ATF2, Bim, and VDAC1 hierarchically operate together,
which has not been reported to date. Although it is
known that ATF2 can function upstream of Bim, at least
in some paradigms of apoptosis, it has never been indi-
cated that Bim might seat in a intermediate position be-
tween ATF2 and VDAC1, as present here. Furthermore,
BAX and VDAC1 were reported to assemble amulti-
meric channel, large enough for the release of proteins
[23-25]. Similarly, the biophysical interactions between
Bim, ATF2, and VDAC1 might be important cytochrome
c release. The requirement of ATF2 for cytochrome c re-
lease and its functional interaction with Bim indicate
ATF2 as being critical factor in mediatting cell death.
Future work must address the biochemical mechanisms
underlying the cooperation between Bim and VDAC1.
Interestingly, it has been shown that Bax and VDAC1
can form a large, multimeric channel that allows for the
release of proteins. Hence, it will be important to inves-
tigate the putative physical and functional interactions
between Bim, Bax and VDAC1 in the context of PTX-
triggered cell death.
Concerning the function of ATF2 on tumorigenesis,we
detected increased proliferation in tumors from an ATF2-
deficient B16F10 cell line injected into C57BL/6 mice,
Figure 5 ATF2 localization induces mitochondrial membrane damage, mitochondrial cytochrome c release, and caspase activation in
B16F10 cells. (A) B16F10 cells stably transfected with scrambled or ATF2 shRNA were incubated with either PTX or CCCP (50 M, 1 h). The cells
were stained with JC-1 dye and observed the mitochondrial membrane potential by fluorescence microscopy. Green fluorescence indicates JC-1
stained mitochondrial plasma with a low JC-1 concentration (monomer) and depolarized mitochondrial membrane potential; red fluorescence
indicates JC-1 stained mitochondrial plasma with a high JC-1 concentration (polymer)(Scale bar: 20 μm). (B) B16F10 cells stably transfected with
scrambled or ATF2 shRNA were treated as indicated above. JC-1 flow cytometry analysis was performed and the represented diagrams of flow
cytometry were presented. B16F10 cells stably transfected with scrambled or ATF2 shRNA were treated as indicated. The cells then were
subjected to immunofluorescently stain with cytochrome c (Scale bar: 20 μm) (C) and immunoblot analysis for the mitochondrial and cytoplasmic
extracts with the indicated antibodies (D).
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Figure 6 Tumorigenicity of ATF2 in vivo. B16F10 cells stably transfected with ATF2T52A or ATF2 shRNA were injected into C57/BL6 mice and
the tumor volume for ATF2T52A tumor xenografts (A) and ATF2 shRNA tumor xenografts (B) was measured on the indicated day. Bars indicate
s.e.m. *P < 0.01, Student’s t test. (C) The ATF2 mRNA levels in the cancer tissues isolated from tumor xenograft mice were measured by quantitative
real-time RT-PCR (ANOVA, *P < 0.01, n = 6). (D) Representative pictures of mice bearing tumors at 3 weeks after B16F10 cells injection. (E) Mitochondrial
and nuclear fractions were prepared from tumor xenografts and subjected to western blotting with an anti-ATF2 antibody at 3 weeks after B16F10
cells injection. The morphometry of ATF2 are indicated at right. The columns provide average values of at least 3 independent experiments
performed in triplicate; the bars, SE. *P < 0.01 compared with the corresponding control. (F) After injection of the indicated tumor cells for
6 days, the xenografts were collected, and the in situ tumor cells were harvested and subjected to FACS apoptosis analyses by Annexin V/PI
staining. Diagram presented quantitative analysis of three similar experiments. *P < 0.01, ANOVA. Data are means ± s.e.m.
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depletion cells. In fact, the mice that displayed an in-
creased growth of B16F10 cells also showed a lowerexpression of ATF2 in the tumor tissue. This dominance
has been detected in several other tumors [26,27]. Hence,
we believe that the ATF2 may be more important in
Liu et al. Cancer Cell International  (2015) 15:34 Page 14 of 14promoting tumor growth in this model, and it can be
speculated that ATF2 might initially contribute to the
events towards tumor proliferation.
Conclusions
The current results bring light on the mechanism of
mitochondrial ATF2 signaling via Bim and VDAC1 dur-
ing cell apoptosis induced by PTX . Thus, ATF2 appear
to be a promising apoptotic target for the therapeutic
agents to work on, whereby targeting ATF2 to tumor
cells suppressing proapoptotic proteins like Bcl-2 and
HK1 would reduce the mechanisms for cancer cells self
defense, accordingly, promoting cellular sensitivity to
therapeutic ahents through increasing apoptosis. These
observations provide full understanding of the mechan-
ism role of ATF2 in modulation of antiangiogenic
function, which might have implications in the future
therapeutic agents design.
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